BIOMAT Database Logo BIOMAT Database Logo

A case of late onset cardiac amyloidosis with a new transthyretin variant (lysine 92). 2001

F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
Department of Cardiology, Surugadai Nihon University Hospital, Tokyo, Japan.

A new transthyretin (TTR) variant (lysine 92), which causes late onset cardiac amyloidosis, is described in a 71-year-old man. The patient at first had syncope due to ventricular tachycardia and was admitted our hospital. Typical findings of cardiac amyloidosis were observed by echocardiography, and a diagnosis of systemic amyloidosis was made by rectal biopsy. The man died approximately 3 years and 6 months after first admission, with gradually worsening congestive heart failure. Pathological examination showed prominent amyloid deposits in the heart and the vascular wall of many organs including the liver, pancreas, kidney, lung, and gastrointestinal tracts. Amyloid protein of transthyretin type was indicated by immunohistochemical study, and DNA sequencing identified a novel mutation in the transthyretin gene encoding 92 glutamine --> lysine. A polymerase chain reaction-induced mutation restriction analysis with a mismatched antisense primer showed that the patient was heterozygous for the TTR Lys92 allele.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D011228 Prealbumin A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease. Proalbumin,Transthyretin
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005192 Family Health The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members. Health, Family
D005260 Female Females
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
Transthyretin ILE20, a new variant associated with late-onset cardiac amyloidosis.
January 1997, Human mutation,
F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis.
December 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
Transthyretin valine-94-alanine, a novel variant associated with late-onset systemic amyloidosis with cardiac involvement.
December 2007, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.
February 1997, The New England journal of medicine,
F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
Late-onset Hereditary ATTR Amyloidosis with a Novel p.P63S (P43S) Transthyretin Variant.
February 2021, Internal medicine (Tokyo, Japan),
F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
[Late-onset hereditary transthyretin amyloidosis with polyneuropathy. Report of one case].
September 2022, Revista medica de Chile,
F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
Transthyretin VAL107, a new variant associated with familial cardiac and neuropathic amyloidosis.
January 1994, Human mutation,
F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation.
March 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
August 1993, British heart journal,
F Saito, and M Nakazato, and H Akiyama, and Y Kitahara, and Y Date, and Y Iwasaki, and S Harasawa, and R Hisaki, and T Horie, and N Kinukawa, and T Watanabe, and T Sakamaki, and H Yagi, and Y Hoshii, and C Yutani, and K Kanmatsuse
Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement.
May 1992, Human genetics,
Copied contents to your clipboard!